OMIC E-Bulletin Announcements

This page was last updated on 08/06/2010

		Coverage Question of the Month
		Risk Management Forms and Documents Update
		New Online Risk Management Courses

I am in a group practice but also have my own limited liability corporation (LLC). Does my corporation need to be named on my policy?

It would be in your best interest to add your personal corporation to the policy since coverage applies only to those medical entities and sole shareholder corporations specifically named on the Declarations. Even if your services are primarily billed and advertised under the group's name, a savvy plaintiff's attorney could name your corporation as a co-defendant in a claim arising from services you render. Your corporation is also at risk if it employs health care providers or ancillary medical staff.

If you choose to include your sole shareholder corporation at shared limits, no additional premium will apply. Coverage may be added at separate limits for an additional charge.

• Chalazion consent form.
• Kenalog Injection consent form.
• Mitomycin-C with Corneal Surgery consent addendum.
• Punctal Plugs consent form.
• Restylane Injection consent form.

• The ALT/SLT consent form has been amended to be a "stand-alone" document. The former version was inadvertently attached to the glaucoma filtering surgery consent form.
• The Avastin™ consent form has been revised to better address the possible increased risk of stroke in Lucentis.
• The Cataract Surgery consent form has been significantly revised and shortened at the request of OMIC policyholders. This version contains the information that OMIC recommends the ophthalmologist personally discuss with the patient. See the "Risk Management Recommendations" section below for a patient information sheet and loss prevention advice.
• The Fluorescein Angiography consent form has been revised.
• The LASIK and PRK consent forms have been revised to better address ectasia and pupil size. Click here for LASIK, here for IntraLASIK, here for retreatment, and here for PRK.
• Lucentis was recently approved for an additional indication. Our consent form has been revised to address treatment of macular edema associated with retinal vein occlusion. Click here to download it.

New Online Risk Management Courses

• Ophthalmic Anesthesia Liability helps ophthalmologists reduce the likelihood of anesthesia-related malpractice claims and includes a video on Sub-Tenon's anesthesia. Please contact Linda Nakamura at (800) 562-6642, ext. 651 or 652, or email lnakamura@omic.com to register for the course.
• Responding to Unanticipated Outcomes is nearly complete. OMIC has always encouraged its policyholders to communicate honestly and compassionately with their patients about care outcomes. Using actual calls to our Risk Management Hotline, this course provides recommendations on disclosure discussions, documentation, event analysis, and refunding fees.